This approach successfully eliminated CXCR4+ cancer cells in solid tumor xenograft models, inducing potent antineoplastic effect while minimizing leucocytosis and toxicity in normal CXCR4+ tissues [236]. This evidence concerns the gene CXCR4 and cancer.